Repository logo
 
No Thumbnail Available
Publication

Efficacy of intravenous immunoglobulin in shrinking lung syndrome associated with mixed connective tissue disease: a case report

Use this identifier to reference this record.
Name:Description:Size:Format: 
Efficacy_intravenous.pdf409.12 KBAdobe PDF Download

Advisor(s)

Abstract(s)

Shrinking lung syndrome is a rare manifestation of connective tissue diseases, namely systemic lupus erythematosus. It is characterised by reduced lung volumes and extra-pulmonary restrictive ventilatory pattern with good response to high-dose glucocorticoids alone or in combination with a second immunosuppressive agent. Here, we describe a case associated with mixed connective tissue disease and effectively treated with intravenous immunoglobulin.

Description

© Copyright Clinical and Experimental Rheumatology 2022.

Keywords

Shrinking lung syndrome Therapy Intravenous immunoglobulin Outcome

Pedagogical Context

Citation

Clin Exp Rheumatol. 2022 May;40 Suppl 134(5):116-117

Research Projects

Organizational Units

Journal Issue